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ABSTRACT
Objective: Antibiotic resistance is a serious problem worldwide. One cause of antibacterial resistance is the inappropriate use of antibiotics. The 
study of antibiotic use in hospitals found that 30–80% were not based on indications. Antimicrobial Stewardship Programs (ASP) was developed to 
control antimicrobial resistance. This study aims to evaluate the impact of ASP in pneumonia patients qualitatively and quantitatively pre-post ASP 
applied. 
Methods: This research is a non-experimental study. Data were taken from the medical records of pneumonia patients and analyzed qualitatively 
using the Gyssens method and quantitatively using the Defined Daily Dose (DDD) method. Sampling was conducted through purposive sampling and 
results were described descriptively.
Results: During the study period, 96 samples were obtained with 48 data pre-ASP and 48 data post-ASP. The results of the qualitative analysis using 
the Gyssens method show an increase in the prudent use of antibiotics from 31.25% to 62.5% pre-post ASP, respectively. Quantitative evaluation 
shows a decrease of antibiotic use pre-post ASP from 90.84 DDD/100 patients-days to 61.42 DDD/100 patients-days. 
Conclusion: The ASP can improve the quality of antibiotic use in pneumonia patients quantitatively and qualitatively.
Keywords: Antimicrobial stewardship program, Gyssens, Pneumonia, Quantitative, Qualitative.
INTRODUCTION
Antibiotics resistance has become a serious problem worldwide. 
The acceleration of the discovery of new antibiotics cannot equal 
the acceleration of bacterial resistance to antibiotics. The cause of 
bacterial resistance to antibiotics is inappropriate or irrational use of 
antibiotics [1,2]. About 40–62% found inappropriate use of antibiotics 
against diseases that should not require antibiotics, whereas in the 
study of antibiotic use in hospitals it was found that 30–80% were 
not based on indications [3]. Poor knowledge and misunderstanding 
of antibiotic treatment are also factors in the increased occurrence of 
resistance [4]. 
Efforts to prevent antibiotic resistance have been launched both 
internationally and nationally. Antimicrobial stewardship program 
(ASP) in hospitals aims to optimize antimicrobial prescribing to obtain 
optimal use of antibiotics, prevents the development of antibiotic 
resistance, improves individual patient care as well as reduce hospital 
costs, and slows the spread of antimicrobial resistance [5]. Based on 
Indonesian Health Ministry regulations concerning ASP in hospitals, 
this program is an attempt to control antimicrobial resistance through 
preventing selective pressure by applying prudent use of antibiotics 
and prevents spreading by implementing infection control prevention 
(Proton Pump Inhibitors) [6]. To find out the effectiveness of the ASP 
program, it is necessary to evaluate the use of antibiotics in hospitals. 
Surveillance study of antibiotic use was carried out quantitatively and 
qualitatively, pre-post ASP. 
Indicator of antibiotic use in hospitals quantitatively is through 
evaluating the reduction in the quantity of antibiotic use. The Defined 
Daily Dose (DDD)/Anatomical Therapeutic Chemical (ATC) method has 
been recommended by the WHO for the evaluation of antibiotic use. 
The advantage of this method is that there is no influence from price 
changes, dosage forms, and easy for comparison at the institutional 
to international level [7], while the qualitative indicator used is the 
Gyssens algorithm. Gyssens algorithm consists of questions that 
classified to compile and simplify the evaluation process; therefore, it 
helps in categorizing antibiotic prescribing [8].
One of the infectious diseases with high occurrence and cause of 
death in Indonesia is pneumonia. The prevalence of death due to 
pneumonia in Indonesia is around 1.8–4.5% in 2013 [9]. The incidence 
of pneumonia in Central Java has reached 26.76%. During the past 
10 years, there has been an increase in pneumococcal resistance, 
especially against penicillin. Increased resistance to penicillin is also 
predicted to have an impact on increasing resistance to several classes 




This research is a non-experimental study. This study used medical 
records taken from the teaching hospital. Collected data were analyzed 
qualitatively using the Gyssens method and quantitatively using the 
DDD method. DDD is the average daily dose of antibiotic use in adults. 
Tools and materials
The tools used in the study are Gyssens diagram, clinical practice 
guidelines, Guidelines for Diagnosis and Management of Community 
and Nosocomial Pneumonia in Indonesia at PDPI (Persatuan Dokter 
Paru Indonesia), Informasi Obat Nasional Indonesia (2017), and the 
WHO Collaborating Center for Drug Statistics Methodology. Data 
were obtained from the medical records of pneumonia patients. 
Before the study was conducted, research approval was obtained 
from the health research ethics committee, the medical faculty of 
Universitas Muhammadiyah Surakarta No.1912/B.1/KEPK-FKUMS/
II/2019.
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Data collection
The data used in this study were secondary data derived from medical 
records of pneumonia patients. The population of the study was all 
inpatients with pneumonia at the teaching hospital in Surakarta. The 
sampling method used purposive sampling following the inclusion and 
exclusion criteria. Inclusion criteria are hospitalized patients with a 
diagnosis of pneumonia and receiving antibiotics, while the exclusion 
criteria are patients with two or more infectious diseases, death, and 
forced discharge. The sample was taken 3 months’ pre-post ASP. Pre-
ASP data were collected from October to November 2016 and post-ASP 
data were collected on June 2018 to August 2018. In February 2017, 
antimicrobial stewardship committee was formed and March 2018 ASP 
started to implement. Collecting included medical record number, sex, 
age, diagnosis, laboratory data (blood test, serum glutamate-pyruvate 
transaminase, and serum glutamic-oxaloacetic transaminase, SrCr), 
and supporting examinations such as chest X-ray, culture examination 
results (if any), antibiotic name, dose, frequency, route, and duration of 
drug administration, and length of stay (LOS).
Data analysis
Data were analyzed and presented descriptively. The assessment or 
evaluation of antibiotic use was done qualitatively with the Gyssens 
algorithm [3]. The assessment of antibiotic use was obtained from the 
amounts contained in categories 0 and I-VI expressed as a percentage. 
Category 0 is the appropriate use of antibiotics, Category I is the use 
of antibiotics in inappropriate time, IIA is the use of antibiotics in 
incorrect dosage, IIB is the use of antibiotics in inappropriate interval of 
administration, IIC is the administration of antibiotics in wrong route, 
IIIA is long duration of antibiotics, IIIB is short duration of antibiotics, 
IVA is another more effective antibiotic options, IVB is relatively safe 
or less toxic antibiotic choices, IVC is another cheaper antibiotics 
options, IVD is another antibiotic choices with narrower spectrum, V 
is no indication of antibiotic use, and VI is incomplete medical record 
and cannot be evaluated. Category 0 is appropriate; Category V is 
unjustified; Category VI is uncategorized because of insufficient of 
medical records or medical records is not complete; and Categories I, II, 
III, and IV indicate inappropriate use of antibiotics.
Quantitative data taken include age, sex, type of antibiotic, the strength 
of the drug, frequency of use, mode of administration, length of 
administration, and LOS. The data were then tabulated based on the 
type of antibiotic, drug strength, dosage form, and ATC classification 
determined by the WHO Collaborating Center for Drug Statistics 
Methodology. The number of uses was calculated by multiplying the 
frequency with the LOS of the patient receiving antibiotics, the total 
strength of the antibiotics used (strength×number of antibiotic use), 
total per group, and LOS by summing all patient days. Quantitative 
analysis was performed using the DDD method.
Dose (DDD) unit DDD/100 patient-days:
     
    100 
100      
− =
thenumber of grams of
DDD ABused bythe patientpatient days x
DDD WHO standard in gram total LOS
RESULTS
During the study period, a total of 96 patients’ medical records data 
fulfilled the inclusion and exclusion criteria. Forty-eight data were 
taken pre-ASP and 48 data post-ASP. As for the quantitative evaluation, 
one data were excluded because it was a pediatric patient. Pediatric 
patients cannot be combined with adult patients in terms of DDD 
calculation. Table 1 shows the characteristics of inpatients pneumonia 
at a teaching hospital in Surakarta.
Based on Table 1, the prevalence of pneumonia pre-post ASP in men 
is higher (58.3% and 60.4%, respectively) than women (41.7% and 
39.6%, respectively). Based on age, pneumonia patients suffered a lot 
at the age of 18–64 years. There were more CAP patients than HAP 
patients. According to Howie et al., 2016, CAP pneumonia is the most 
common occurrence. Streptococcus pneumoniae is the most common 
cause of CAP worldwide [11].
The average LOS of pneumonia patient’s pre-post ASP was 9.87 days 
and 10.04 days, respectively. According to Watkins, 2009, the effective 
duration of antibiotic therapy for pneumonia is 10–14 days [12]. Day of 
care is calculated from the time the patient enters to leave the hospital 
with a discharge status or in recovery according to inclusion criteria. 
LOS is the length of time each patient was hospitalized obtained by 
dividing the number of days of stay with the number of patients. 
Decreased LOS is associated with decreased antibiotic use [13]. 
Antibiotics are the main therapy for pneumonia caused by bacteria, 
where the initial antibiotic used is broad-spectrum empirical 
antibiotics while waiting for the results of the cultures. The use of 
empirical antibiotics is administered in the case of certain bacteria 
that have not been found. Definitive therapy for antibiotics is the use 
of antibiotics based on microbiological examination results. After the 
presence of ASP, antibiotic therapy based on culture testing (definitive) 
has increased from 29.75% to 64.56%.
The results of the quantitative evaluation of antibiotic use with the DDD 
method pre-post ASP areshown in Table 2.
The results of the quality of antibiotic use evaluation by the Gyssens 
method pre-post ASP are shown in Fig. 1.
Table 1: Characteristics of pneumonia inpatients before and after ASP
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CAP: Community-acquired pneumonia, HAP: Hospital-acquired pneumonia
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DISCUSSION 
Evaluate the use of antibiotics quantitatively
Ceftriaxone is the most widely used antibiotic (31.47 DDD/100 patients-
days) before ASP. Based on Moremi’s study (2016), 80.6% of Klebsiella 
pneumonia cause pneumonia more resistant to cephalosporins and 
resistance to third-generation cephalosporins, in which the resistance 
increased from 26.5% in 2014 to 57.9% in 2015 [14]. Post-ASP, 
ceftriaxone is not widely used because it has entered the red group 
under the clinical practice guidelines for the use of antibiotics in 
Surakarta teaching hospitals. This guideline is classified according 
to red/reserve, yellow/watch, and green/access. The red group or 
reserved antibiotic is an antibiotic that should be considered last-
resort options and used only in the most severe circumstances when 
all other alternatives have failed. In this study, there is an improvement 
in the use of antibiotics that can be seen from the change in the use 
of antibiotics which used to be more red-type antibiotics, which is 
ceftriaxone pre-ASP to green-type antibiotics namely Ampicillin 
Sulbactam post-ASP. Pre-ASP, ceftriaxone (32.87 DDD 100 patients) 
is the most commonly prescribed antibiotic, while Post-ASP, the most 
common antibiotic is Ampicillin Sulbactam (36.71 DDD 100 patients). 
In line with the Newman (2012) study reporting that ceftriaxone 
use decrease from 72% to 21% after the implementation of clinical 
practice guidelines and ASP in a tertiary care children’s hospital in 
the city of Kansas, Missouri, USA. Pre-clinical practice guidelines and 
ASP, ceftriaxone (72%) is the most commonly prescribed antibiotic, 
followed by ampicillin (13%). Post-clinical practice guidelines, the 
most common antibiotic is ampicillin (63%) [15].
The number of antibiotic use in the hospital can be calculated using 
the DDD method with DDD/100 patient-days which illustrates patients 
who receive the definitive daily dose (DDD). A high DDD value can be 
influenced by the amount of antibiotic use. The total use of antibiotics 
in pneumonia patients hospitalized in Surakarta teaching hospital 
pre-post ASP decreased from 90.84 DDD/100 patient-days to 61.42 
DDD/100 patients-days. The greater the total value of DDD/100 patient-
days, the higher the level of antibiotic use in 100 days of treatment and 
vice versa. 
Evaluate the use of antibiotics qualitatively
One of the goals of the ASP establishment is to provide optimal antibiotic 
therapy, the use of the appropriate antibiotics, the correct dosage, which 
has the least possible resistance and to prevent abuse and excessive use 
of antibiotics [16]. There is an increase in the prudent use of antibiotics 
from 31.25% to 62.5% pre-post ASP, respectively. Category 0 (the use of 
appropriate) pre-post ASP shows 31.25% and 62.5%, respectively. The 
rational use of antibiotics will have an impact on decreasing antibiotic 
resistance, increasing the efficacy of antibiotic use, and support patient 
safety programs. Furthermore, it can also reduce the morbidity and 
mortality caused by antibiotic resistance [16].
Based on the clinical practice guidelines, inpatients without 
modification factors, the recommended choice of antibiotic groups 
is betalactam+antibetalactamase iv or the 2nd or 3rd cephalosporin 
iv, or fluoroquinolone respiration iv. Inpatients with modification 
factors, the recommended choices of antibiotic groups are the 2nd or 
3rd cephalosporin iv, or fluoroquinolone respiration iv. The atypical 
bacterial suspect infection can use new macrolides. 
In Category IV A (another more effective antibiotic alternatives), 
it shows a decrease of 33.33% pre-ASP to 14.58% post-ASP. Pre-
ASP, several antibiotics were prescribed in combination between 
cephalosporins (ceftriaxone) and fluoroquinolones (levofloxacin) or 
cephalosporins with macrolides such as azithromycin so that they are 
included as IV A. There is also a case; according to the results of the 
culture examination the patient was resistant to ceftriaxone, but the 
doctor prescribed ceftriaxone, whereas there are other more effective 
Table 2: Results of the quantity of antibiotic use in pneumonia patients pre-post ASP
DDD Antibiotics Total DDD DDD/100 patients Total DDD/100 patients
Before J01DD04 Ceftriaxone (1000 mg) 6.50 1.40 90.84
Ceftriaxone (2000 mg) 146 31.47
J01DH02 Meropenem (500 mg) 3.75 0.81
J01DD02 Ceftazidime (1000 mg) 9 1.94
J01MA12 Levofloxacin (750 mg) 135 29.09
J01MA02P Ciprofloxacin (400 mg) 40 8.62
J01FA10 Azithromycin (500 mg) 64.17 13.83
JO1GB03 Gentamicin (160 mg) 17.07 3.68
After J01DD04 Ceftriaxone (2000 mg) 13 2.75 61.42
J01DH02 Meropenem (500 mg) 9 1.91
J01MA12 Levofloxacin (750 mg) 78 16.53
J01FA10 Azithromycin (500 mg) 11.67 2.47
J01CR01 Ampicillin Sulbactam (1500 mg) 173.25 36.71
J01CA01 Ampicillin (1000 mg) 5 1.06
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antibiotic options such as ampicillin or ceftazidime according to the 
results of a more sensitive culture.
Category VI also shows a decrease in pre-post ASP, from 20.83% to 
6.25%. The data included in Category VI are incomplete data such 
as medical records without a diagnosis, or there is a missing medical 
record page so it cannot be evaluated. Overall, there is an improvement 
in the prudent use of antibiotics consist of improving the appropriate 
use of antibiotics, reducing the incorrect dosage of antibiotics, reducing 
the incorrect duration of antibiotics, and improving a better antibiotics 
selection due to higher efficacy and lower toxicity. 
Antibiotics stewardship improve antibiotic’s prudent use of 
qualitatively and quantitatively. Antibiotics stewardship commit to 
always use antibiotics only when they are necessary to treat infection 
and prevent infection as a prophylactic with the right antibiotics, the 
right dose, duration, and to administer in the right way. Antibiotics 
stewardship ensures that every patient gets the maximum benefit 
from the antibiotic use and avoids unnecessary harm from allergic 
reactions and side effects, and helps preserve the life-saving potential 
of antibiotics for the future. Antibiotics stewardship helps improve 
patients care and shorten hospital stays, thus benefiting patients as well 
as the hospital. A University of Maryland study showed one antibiotic 
stewardship program saved a total of USD 17 million over 8 years [17].
Education of the prescriber is important for any successful ASP. The 
teaching of guidelines and clinical pathways could help to improve 
antimicrobial prescribing behavior. Adherence to strict prescribing 
guidelines and a policy of monitoring rational antibiotic use are part of 
any successful ASP as well [18,19]. 
Strength and limitation study
This study was conducted on one infectious disease, so it could not 
find the overall quality profile of antibiotic use in Surakarta teaching 
hospital. However, focusing only on one infection will find a deeper 
understanding of the use of antibiotics qualitatively and quantitatively 
in pneumonia. This research was conducted retrospectively so that the 
existing medical record data could not be confirmed to the physician 
who prescribed antibiotics, the researcher could not find out the reason 
for the doctor regarding antibiotic selection considerations.
CONCLUSION
Based on the conducted research, there are differences in the quality of 
antibiotic use among pre-and post-ASP in pneumonia patients. Judging 
from the results of the qualitative analysis using the Gyssens method 
shows an increase in the antibiotics prudent use from 31.25% pre-
ASP to 62.5% post-ASP. In terms of quantity, there is a decrease in total 
DDD/100 patient-days pre-ASP (90.84 DDD/100 patients-days) and 
post-ASP (61.42 DDD/100 patients-days). Thus, it shows a decrease in 
the level of antibiotic use in Surakarta teaching hospitals. In this study, it 
is also shown from the replacement of a red/reserve group of antibiotics 
(Ceftriaxone) into a green/access group (Ampicillin Sulbactam). 
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